FDA product code OPX: Immunoglobulin A Kappa Heavy & Light Chain Combined

OPX is the FDA product code for immunoglobulin a kappa heavy & light chain combined. It is a Class II device, regulated under 21 CFR 866.5510 and reviewed by the Immunology panel. FDA has cleared 3 510(k) submissions under OPX, from 2 different applicants. The average 510(k) review took 92 days (median 84).

Definition

Intended for the in-vitro quantification of iga kappa concentration in human serum. The result is to be used with previously diagnosed iga multiple myeloma, in conjunction with other clinical and laboratory findings. For previously diagnosed iga multiple myeloma patients.

Classification

FieldValue
Device nameImmunoglobulin A Kappa Heavy & Light Chain Combined
Device classClass II
Regulation21 CFR 866.5510
Review panelIM — Immunology
Medical specialtyImmunology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every OPX clearance

Top OPX applicants

ApplicantClearancesLatest
The Binding Site Group , Ltd.22016-06-16
The Binding Site12014-03-18

Most recent OPX clearances

510(k)ApplicantDeviceDecision dateReview days
K160819The Binding Site Group , Ltd.Optilite Hevylite IgA Kappa Kit, Optilite Hevylite IgA Lambda Kit2016-06-1684
K151759The Binding Site Group , Ltd.Hevylite Human IgA Kappa Kit for use on SPAPLUS, Hevylite Human IgA Lambda Kit for use on SPAPLUS2015-11-06130
K140105The Binding SiteHEVYLITE HUMAN IGA KAPPA KIT FOR USE ON SIEMENS BNII, HEVYLITE HUMAN IGA LAMBDA KIT FOR USE ON SIEMENS BNII2014-03-1862

Recalls for OPX devices

openFDA lists no recalls for product code OPX.

Frequently asked questions

What is FDA product code OPX?

OPX is the FDA product code for immunoglobulin a kappa heavy & light chain combined. It is a Class II device, regulated under 21 CFR 866.5510 and reviewed by the Immunology panel.

What device class is OPX?

Class II, regulation 21 CFR 866.5510. Typical premarket route: 510(k).

How long does a 510(k) take for product code OPX?

Across 3 cleared submissions the average was 92 days from receipt to decision (median 84).

Which companies have the most OPX clearances?

The Binding Site Group , Ltd. (2); The Binding Site (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times